Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.
Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback